Titre : Mouvements de l'eau

Mouvements de l'eau : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Neoplasms
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mouvements de l'eau : Questions médicales les plus fréquentes", "headline": "Mouvements de l'eau : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mouvements de l'eau : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-24", "dateModified": "2025-02-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mouvements de l'eau" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Environnement", "url": "https://questionsmedicales.fr/mesh/D004777", "about": { "@type": "MedicalCondition", "name": "Environnement", "code": { "@type": "MedicalCode", "code": "D004777", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.230" } } }, "about": { "@type": "MedicalCondition", "name": "Mouvements de l'eau", "alternateName": "Water Movements", "code": { "@type": "MedicalCode", "code": "D014872", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ryan S Wagner", "url": "https://questionsmedicales.fr/author/Ryan%20S%20Wagner", "affiliation": { "@type": "Organization", "name": "Department of Biology, Bowling Green State University, Bowling Green, OH, United States." } }, { "@type": "Person", "name": "Katelyn M McKindles", "url": "https://questionsmedicales.fr/author/Katelyn%20M%20McKindles", "affiliation": { "@type": "Organization", "name": "Great Lakes Center for Fresh Waters and Human Health, Bowling Green State University, Bowling Green, OH, United States." } }, { "@type": "Person", "name": "George S Bullerjahn", "url": "https://questionsmedicales.fr/author/George%20S%20Bullerjahn", "affiliation": { "@type": "Organization", "name": "Department of Biology, Bowling Green State University, Bowling Green, OH, United States." } }, { "@type": "Person", "name": "Miguel A Gonzalez", "url": "https://questionsmedicales.fr/author/Miguel%20A%20Gonzalez", "affiliation": { "@type": "Organization", "name": "Universidad Rey Juan Carlos, ESCET, Mostoles, 28933 Madrid, Spain." } }, { "@type": "Person", "name": "Alberto Zaragoza", "url": "https://questionsmedicales.fr/author/Alberto%20Zaragoza", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, The University of Utah, Salt Lake City, Utah 84112-0850, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Presence of HPV in prostate tissue from patients submitted to prostate biopsy.", "datePublished": "2023-01-13", "url": "https://questionsmedicales.fr/article/36651430", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/acb371205" } }, { "@type": "ScholarlyArticle", "name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36253300", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clgc.2022.09.007" } }, { "@type": "ScholarlyArticle", "name": "The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.", "datePublished": "2024-10-20", "url": "https://questionsmedicales.fr/article/39428439", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-76355-4" } }, { "@type": "ScholarlyArticle", "name": "Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37271051", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cmpb.2023.107624" } }, { "@type": "ScholarlyArticle", "name": "Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36917412", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11255-023-03531-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Environnement", "item": "https://questionsmedicales.fr/mesh/D004777" }, { "@type": "ListItem", "position": 4, "name": "Mouvements de l'eau", "item": "https://questionsmedicales.fr/mesh/D014872" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mouvements de l'eau - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mouvements de l'eau", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mouvements de l'eau", "description": "Comment diagnostiquer une déshydratation ?\nQuels tests pour évaluer l'équilibre hydrique ?\nQuels signes indiquent une surcharge hydrique ?\nComment détecter un déséquilibre électrolytique ?\nQuels symptômes nécessitent un diagnostic urgent ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mouvements de l'eau", "description": "Quels sont les symptômes de la déshydratation ?\nComment reconnaître une surcharge hydrique ?\nQuels signes indiquent un déséquilibre hydrique ?\nQuels symptômes sont liés à l'hyperhydratation ?\nQuels symptômes d'un choc hypovolémique ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mouvements de l'eau", "description": "Comment prévenir la déshydratation ?\nQuelles mesures pour éviter la surcharge hydrique ?\nComment maintenir un bon équilibre hydrique ?\nQuelles précautions pour les athlètes ?\nComment prévenir les déséquilibres électrolytiques ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mouvements de l'eau", "description": "Comment traiter la déshydratation légère ?\nQuel traitement pour la surcharge hydrique ?\nComment gérer un déséquilibre électrolytique ?\nQuel est le traitement de l'hyperhydratation ?\nComment traiter un choc hypovolémique ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mouvements de l'eau", "description": "Quelles complications de la déshydratation sévère ?\nQuels risques d'une surcharge hydrique prolongée ?\nQuelles complications d'un déséquilibre électrolytique ?\nQuels dangers de l'hyperhydratation ?\nQuelles complications du choc hypovolémique ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mouvements de l'eau", "description": "Quels facteurs augmentent le risque de déshydratation ?\nQui est à risque de surcharge hydrique ?\nQuels médicaments augmentent le risque d'un déséquilibre électrolytique ?\nQuels comportements augmentent le risque d'hyperhydratation ?\nQuels facteurs de risque pour le choc hypovolémique ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déshydratation ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par l'évaluation des symptômes cliniques et des tests sanguins." } }, { "@type": "Question", "name": "Quels tests pour évaluer l'équilibre hydrique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins, urinaires et des mesures de poids peuvent être utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une surcharge hydrique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent œdème, hypertension et dyspnée." } }, { "@type": "Question", "name": "Comment détecter un déséquilibre électrolytique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Par des analyses sanguines mesurant les niveaux de sodium et potassium." } }, { "@type": "Question", "name": "Quels symptômes nécessitent un diagnostic urgent ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Confusion, convulsions ou perte de conscience doivent être évalués rapidement." } }, { "@type": "Question", "name": "Quels sont les symptômes de la déshydratation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Soif intense, sécheresse de la peau, fatigue et urine foncée." } }, { "@type": "Question", "name": "Comment reconnaître une surcharge hydrique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes incluent gonflement des membres, essoufflement et prise de poids rapide." } }, { "@type": "Question", "name": "Quels signes indiquent un déséquilibre hydrique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, crampes musculaires et troubles de la concentration." } }, { "@type": "Question", "name": "Quels symptômes sont liés à l'hyperhydratation ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Nausées, maux de tête et confusion mentale peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes d'un choc hypovolémique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Pulsations rapides, peau froide et confusion mentale sont des indicateurs." } }, { "@type": "Question", "name": "Comment prévenir la déshydratation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Boire régulièrement de l'eau, surtout par temps chaud ou lors d'exercices." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la surcharge hydrique ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Limiter l'apport en liquides et surveiller les signes d'œdème." } }, { "@type": "Question", "name": "Comment maintenir un bon équilibre hydrique ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Consommer des aliments riches en eau et surveiller l'apport en électrolytes." } }, { "@type": "Question", "name": "Quelles précautions pour les athlètes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "S'hydrater avant, pendant et après l'exercice pour éviter la déshydratation." } }, { "@type": "Question", "name": "Comment prévenir les déséquilibres électrolytiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Avoir une alimentation équilibrée et surveiller les niveaux lors de maladies." } }, { "@type": "Question", "name": "Comment traiter la déshydratation légère ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "L'hydratation orale avec des solutions électrolytiques est recommandée." } }, { "@type": "Question", "name": "Quel traitement pour la surcharge hydrique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Restriction hydrique et diurétiques peuvent être prescrits." } }, { "@type": "Question", "name": "Comment gérer un déséquilibre électrolytique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments ou des modifications alimentaires peuvent être nécessaires." } }, { "@type": "Question", "name": "Quel est le traitement de l'hyperhydratation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Réduction de l'apport hydrique et administration de diurétiques." } }, { "@type": "Question", "name": "Comment traiter un choc hypovolémique ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Administration rapide de fluides intraveineux et traitement de la cause sous-jacente." } }, { "@type": "Question", "name": "Quelles complications de la déshydratation sévère ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Peut entraîner des lésions rénales, des convulsions et un choc hypovolémique." } }, { "@type": "Question", "name": "Quels risques d'une surcharge hydrique prolongée ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Peut causer un œdème pulmonaire et des troubles cardiaques." } }, { "@type": "Question", "name": "Quelles complications d'un déséquilibre électrolytique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Peut entraîner des arythmies cardiaques et des troubles neurologiques." } }, { "@type": "Question", "name": "Quels dangers de l'hyperhydratation ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Peut provoquer un œdème cérébral et des troubles de la conscience." } }, { "@type": "Question", "name": "Quelles complications du choc hypovolémique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Peut entraîner une défaillance multi-organique et un décès si non traité." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de déshydratation ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Âge avancé, maladies chroniques et climat chaud sont des facteurs de risque." } }, { "@type": "Question", "name": "Qui est à risque de surcharge hydrique ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes avec insuffisance cardiaque ou rénale sont particulièrement à risque." } }, { "@type": "Question", "name": "Quels médicaments augmentent le risque d'un déséquilibre électrolytique ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les diurétiques et certains laxatifs peuvent provoquer des déséquilibres." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque d'hyperhydratation ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une consommation excessive de liquides sans équilibre électrolytique peut être risquée." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le choc hypovolémique ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Traumatismes, hémorragies et déshydratation sévère augmentent le risque." } } ] } ] }

Sources (10000 au total)

Presence of HPV in prostate tissue from patients submitted to prostate biopsy.

Prostate cancer (PCa) is the second most frequent cancer among men in the Western population. Infections, such as the one caused by the human papillomavirus (HPV), have been shown to promote inflammat... Prostate tissue fragments were collected by prostate biopsy and subjected to polymerase chain reaction with primers for the HPV L1 gene to identify the presence of the virus.... Among 162 patients, 10 (6.2%) had HPV and in 152 (93.8%) HPV was not identified in prostate biopsies. HPV was detected in 7/95 (7.4%) of patients with PCa, in 2/55 (3.6%) of patients without PCa, and ... There were no significant levels of HPV L1 protein in prostate tissue. The findings suggest the absence of HPV oncogenic activity in the prostate tissue of patients with PCa....

Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.

In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals.... This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ... It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high... As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...

Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.

With emerging evidence to improve prostate cancer (PCa) screening, multiparametric magnetic prostate imaging is becoming an essential noninvasive component of the diagnostic routine. Computer-aided di... We collected 1647 fine-grained biopsy-confirmed findings, including Gleason scores and prostatitis, to form a training dataset. In our experimental framework for lesion detection, all models utilized ... An optimal model configuration with fine class granularity (prostatitis included) and OHE has scored the lesion-wise partial Free-Response Receiver Operating Characteristic (FROC) area under the curve... This paper examines several configurations for model training in the biparametric MRI setup and proposes optimal value ranges. It also shows that the fine-grained class configuration, including prosta...

Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.

To assess the efficacy of 2-core prostate biopsy in advanced prostate cancer patients. This included a retrospective analysis of 12-core prostate biopsies and a prospective validation that a reduced n... The first phase analyzed retrospective data from 12-core prostate biopsies between January 2013 and 2018. In the second phase, from January 2018 to January 2022, in a prospective setting, patients wit... In the retrospective analysis, the number of positive cores in metastatic disease was 12 in 93 (73.8%), 11 in 14 (11.1%), and 10 in 7 (5.6%) patients. Using probability analysis, 94% of patients with ... A 2-core biopsy is adequate in almost all patients with metastatic prostate cancer with PSA > 75, and this avoids excess complications and morbidity associated with a systematic 12-core prostate biops...

Prostate cancer aggressiveness and financial toxicity among prostate cancer patients.

Financial toxicity (FT) is a growing concern among cancer survivors that adversely affects the quality of life and survival. Individuals diagnosed with aggressive cancers are often at a greater risk o... PCa patients enrolled in the North Carolina-Louisiana Prostate Cancer Project (PCaP) were recontacted for long-term follow-up. The prevalence of FT in the PCaP cohort was estimated. FT was estimated u... More than one-third of PCa patients reported experiencing FT. PCa aggressiveness was significantly independently associated with high FT; high aggressive PCa at diagnosis had more than twice the risk ... Aggressive PCa was associated with high FT. Future studies should collect more information about the characteristics of men with high FT and identify additional risk factors of FT....

Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?

Cribriform (CBFM) pattern on prostate biopsy has been implicated as a predictor for high-risk features, potentially leading to adverse outcomes after definitive treatment. This study aims to investiga... Patients who underwent multiparametric magnetic resonance imaging (mpMRI), combined 12-core transrectal ultrasound (TRUS) guided systematic (SB) and MRI/US fusion-guided biopsy were retrospectively qu... Between 2015 and 2022, a total of 131 consecutive patients with CBFM pattern on prostate biopsy and pre-biopsy mpMRI were included. Clinical feature analysis included 1572 systematic biopsy cores (114... The extent of disease for CBFM-containing tumors is difficult to capture on mpMRI. When comparing MRI lesions of similar dimensions and PIRADS scores, CBFM-containing tumors appear to have larger canc...